Meeting support for HIV Evolution and Dynamics

描述(申请人提供)：艾滋病毒进化和动力学会议是一个小型的年度艾滋病毒会议，有十年的历史。这次会议为从事数据分析、数学建模和艾滋病毒进化分析的人们提供了一个具体的机会，可以聚集在一起讨论新的研究及其影响，以及可以应用于艾滋病毒的新的分析工具和方法。这项工作的数学和统计方面的讨论可以比较大的艾滋病毒会议更深入地讨论，这些会议主要集中在实验和临床陈述上。从历史上看，这次会议在欧洲和美国之间交替举行，为大西洋两岸的研究人员提供了更多的机会参加会议。对于直接参与数据分析的艾滋病毒科学家来说，这可能是一年中最重要的会议之一。会议吸引了对体内动力学和疾病进展、考虑到流行史、免疫学和疫苗战略的艾滋病毒全球变异进行建模的个人，以及研究耐药性出现的个人。讲座和海报包括重要的新研究，这些研究具有复杂的方面，这些方面可能更多地从传统观点提出，但从分析的角度进行讨论；以数学为导向的演讲，有机会在典型的艾滋病毒生物学会议上深入探讨更多细节；以及来自艾滋病毒领域以外的科学家的演讲，他们开发了可能有用的新分析方法，可能被引入艾滋病毒研究领域。大约有100到150名科学家参加；这个数字过去取决于地点。有充足的时间进行讨论和发展联系，以促进和扩大正在进行的研究，并发起新的合作努力。传统上，这次会议得到了OAR和CDC的支持，补充资金来自行业和主要组织者在任何一年的筹款努力。从2003年春季会议在箭头湖会议中心举行开始，我们第一次请求NIH-NIAID提供持续的、为期五年的支持。加州大学圣迭戈分校继续医学教育办公室已经提出，在我们申请资助的五年期间，为会议的财务和组织基础设施提供支持，并将直接与主要科学组织者合作，而不考虑他或她的家乡机构。

DESCRIPTION (provided by applicant): The HIV Evolution and Dynamics Meeting is a small annual HIV meeting with a ten-year history. This meeting has given people who do data analysis, mathematical modeling, and HIV evolutionary analyses a specific opportunity to come together to discuss new research, both in terms of new studies and their implications, and new analysis tools and methods that could be applied to HIV. Mathematical and statistical aspects of the work can be discussed in greater depth than is possible in the larger HIV meetings, which primarily focus on experimental and clinical presentations. Historically this meeting has alternated venues between Europe and the US, to allow greater access to the meeting for researchers on both sides of the Atlantic. It can be one of the most important meetings of the year for HIV-scientists directly involved in the analysis of data. The meeting draws individuals who model in vivo dynamics and disease progression, global variation of HIV with considerations of the epidemic history, immunology and vaccine strategies, and individuals that study the emergence of drug resistance. The talks and posters range from important new studies that have complex aspects that may be presented more from a traditional view, but are discussed from an analysis perspective; mathematical oriented talks with an opportunity to go into more detail than is appropriate at typical HIV biology meetings; and talks from scientists outside the HIV field who develop new analysis methods that might usefully be brought into the sphere of HIV research. On the order of 100 to 150 scientists attend; this number has depended on the venue in the past. There is ample time for discussion and developing contacts to facilitate and extend ongoing studies, and to initiate new collaborative efforts. The meeting has traditionally been supported by the OAR and the CDC with supplemental funding coming in through industry and the fund raising efforts of the primary organizer in any given year. For the first time, we are asking for continuing, five-year support from NIH-NIAID, starting with the spring 2003 meeting to be held at Lake Arrowhead conference center. The UCSD Office of Continuing Medical Education has offered to support the financial and organizational infrastructure of the conference for the five-year period for which we are requesting funding, and will work directly with the primary scientific organizer regardless of his or her home institution.